Low-Cost, Point-of-Care Screening and Diagnosis of Preeclampsia/Eclampsia: Novel Biomarkers in a Lateral-Flow Test
We have identified three promising urine-based biomarkers from published proteomic studies; our first project activity will be to develop these three urine-based biomarkers into three respective ELISA for proof-of-concept validation and technology transfer to lateral-flow assays.